Stockreport

Zealand Pharma slump wipes billions off its value after obesity drug data disappoints [Yahoo! Finance]

KBC GROUP SA UNSP/ADR  (KBCSY) 
NASDAQ:AMEX Investor Relations: kbc.com/en/investor-relations
PDF on record, after mid-stage trial results ?for obesity drug petrelintide fell short of investor expectations. The drug, which Zealand is developing ?with Roche, helped [Read more]